Synokem Nods to CDSCO Panel to Investigate Dyhydogestrone in Technology Development Support

Published Date: 13 Mar 2023

NEW DELHI: The Central Drug Standards Control Organization (CDSCO) Securities and Exchange Commission (SEC) has given the drug its approval.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Breast density changes over time are associated with an increased risk of cancer.

2.

How the metastasis of cancer is driven by cellular plasticity.

3.

Belzutifan Combo Could be Second-Line Option in Advanced RCC

4.

Radioligand Shows Promise in Metastatic Hormone-Sensitive Prostate Cancer

5.

Research indicates that extended PSMA therapy is safe and effective for patients with prostate cancer.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot